Resultados da busca - Lakshmi Nayak
- Mostrando 1 - 20 resultados de 36
- Ir para a próxima página
-
1
-
2
Glioblastoma in the elderly por Fábio M. Iwamoto, Anna R. Cooper, Anne S. Reiner, Lakshmi Nayak, Lauren E. Abrey
Publicado em 2009Artigo -
3
-
4
-
5
-
6
-
7
High‐dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first com... por Zachariah DeFilipp, Shuli Li, Areej El‐Jawahri, Philippe Armand, Lakshmi Nayak, Nancy Wang, Tracy T. Batchelor, Yi‐Bin Chen
Publicado em 2017Artigo -
8
-
9
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma por Lakshmi Nayak, Fábio M. Iwamoto, Ann S. LaCasce, Srinivasan Mukundan, Margaretha G.M. Roemer, Bjoern Chapuy, Philippe Armand, Scott J. Rodig, Margaret A. Shipp
Publicado em 2017Artigo -
10
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma por Lakshmi Nayak, Lauren E. Abrey, Jan Drappatz, Mark R. Gilbert, David A. Reardon, Patrick Y. Wen, Michael D. Prados, Lisa M. DeAngelis, Antonio Omuro
Publicado em 2012Artigo -
11
-
12
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative por Linda Dirven, Terri S. Armstrong, Jaishri O. Blakeley, Paul D. Brown, Robin Grant, Rakesh Jalali, Heather Leeper, Tito R. Mendoza, Lakshmi Nayak, Jaap C. Reijneveld, Émilie Le Rhun, Tobias Walbert, Michael Weller, Patrick Y. Wen, Martin Klein
Publicado em 2018Revisão -
13
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab por Raymond Y. Huang, Rifaquat Rahman, Karla V. Ballman, Sara J. Felten, S. Keith Anderson, Benjamin M. Ellingson, Lakshmi Nayak, Eudocia Q. Lee, Lauren E. Abrey, Evanthia Galanis, David A. Reardon, Whitney B. Pope, Timothy F. Cloughesy, Patrick Y. Wen
Publicado em 2015Artigo -
14
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma por Matthew J. Frigault, Jörg Dietrich, Maria Martinez‐Lage, Mark B. Leick, Bryan D. Choi, Zachariah DeFilipp, Yi‐Bin Chen, Jeremy S. Abramson, Jennifer L. Crombie, Philippe Armand, Lakshmi Nayak, Chris Panzini, Lauren S. Riley, Kathleen Gallagher, Marcela V. Maus
Publicado em 2019Artigo -
15
Extent of resection and overall survival for patients with atypical and malignant meningioma por Ayal A. Aizer, Wenya Linda Bi, Manjinder Singh Kandola, Eudocia Q. Lee, Lakshmi Nayak, Mikael L. Rinne, Andrew D. Norden, Rameen Beroukhim, David A. Reardon, Patrick Y. Wen, Ossama Al‐Mefty, Nils D. Arvold, Ian F. Dunn, Brian M. Alexander
Publicado em 2015Artigo -
16
Central nervous system involvement by Waldenström macroglobulinaemia (Bing‐Neel syndrome): a multi‐institutional retrospective study por Jorge J. Castillo, Shirley D’Sa, Michael P. Lunn, Monique C. Minnema, Alessandra Tedeschi, Frederick Lansigan, M. Lia Palomba, Marzia Varettoni, Ramón García‐Sánz, Lakshmi Nayak, Eudocia Q. Lee, Mikael L. Rinne, Andrew D. Norden, Irene M. Ghobrial, Steven P. Treon
Publicado em 2015Artigo -
17
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study por Jorge J. Castillo, Gilad Itchaki, Jonas Paludo, Marzia Varettoni, Christian Buske, Toby A. Eyre, Julio C. Chávez, Kenneth H. Shain, Samar Issa, M. Lia Palomba, Oren Pasvolsky, David Simpson, Dipti Talaulikar, Constantine S. Tam, Alessandra Tedeschi, Stephen M. Ansell, Lakshmi Nayak, Steven P. Treon
Publicado em 2018Artigo -
18
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101 por Tracy T. Batchelor, Sharmila Giri, Amy S. Ruppert, Susan M. Geyer, Scott E. Smith, Nimish Mohile, Lode J. Swinnen, Jonathan W. Friedberg, Brad S. Kahl, Nancy L. Bartlett, Eric D. Hsi, Bruce D. Cheson, Nina D. Wagner‐Johnston, Lakshmi Nayak, John P. Leonard, James L. Rubenstein
Publicado em 2024Artigo -
19
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study por Nicholas Butowski, Howard Colman, John de Groot, Antonio Omuro, Lakshmi Nayak, Patrick Y. Wen, Timothy F. Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry, Jason T. Huse, Joanna J. Phillips, Brian L. West, K. B. Nolop, Henry H. Hsu, Keith L. Ligon, Annette M. Molinaro, Michael D. Prados
Publicado em 2015Artigo -
20
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older por Jacob G. Scott, Luc Bauchet, Tyler J. Fraum, Lakshmi Nayak, Anna R. Cooper, Samuel T. Chao, John H. Suh, Michael A. Vogelbaum, David M. Peereboom, Sonia Zouaoui, Hélène Mathieu‐Daudé, Pascale Fabbro‐Peray, Valérie Rigau, Luc Taillandier, Lauren E. Abrey, Lisa M. DeAngelis, Joanna H. Shih, Fábio M. Iwamoto
Publicado em 2012Artigo
Ferramentas de busca:
Assuntos relacionados
Internal medicine
Medicine
Oncology
Surgery
Cancer
Cancer research
Chemotherapy
Clinical trial
Lymphoma
Immunotherapy
Primary central nervous system lymphoma
Biology
Cohort
Confidence interval
Immunology
Glioma
Immune system
Proportional hazards model
Radiation therapy
Radiology
Bevacizumab
Central nervous system
Environmental health
Glioblastoma
Hazard ratio
Medical physics
Meningioma
Pathology
Population
Receptor